Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reflects strong financial guidance, significant new business revenue, and strategic market expansion plans. The Q&A section provides additional insights into a robust sales pipeline, successful operational initiatives, and strategic wins in aerospace and defense. While management avoided some specifics, the overall sentiment is positive, driven by strong growth prospects and successful integration of acquisitions.
Revenue $3.3 billion, up 11% year-over-year. Reasons for change: Growth driven by resilience and global strength of the business model in a dynamic geopolitical environment.
Adjusted EBITDA $200 million, up 23% year-over-year. Reasons for change: Strong underlying performance and operational improvements.
Adjusted Diluted EPS $0.50, up 72% year-over-year. Reasons for change: Improved profitability and operational efficiency.
Organic Revenue Growth 4% year-over-year. Reasons for change: Contributions from every region, showcasing resilience and global strength.
New Business Wins $227 million in the first quarter. Reasons for change: Notable contracts in aerospace and defense, technology, AI cloud infrastructure, and consumer partnerships.
Incremental New Business Revenue $870 million expected for 2026, up 19% year-over-year. Reasons for change: Strong commercial momentum and strategic wins.
Adjusted EBITDA Margin 6.1%, up 60 basis points year-over-year. Reasons for change: Operational improvements and efficiency gains.
Net Income $5 million. Reasons for change: Not explicitly mentioned.
Adjusted Net Income Attributable to GXO $58 million, up 70.6% year-over-year. Reasons for change: Improved operational performance.
Operating Cash Flow $31 million. Reasons for change: Typical seasonality.
Free Cash Flow Outflow of $31 million. Reasons for change: Typical seasonality.
Cash on Hand $794 million. Reasons for change: Not explicitly mentioned.
Liquidity Position $1.6 billion. Reasons for change: Strong financial management.
Leverage Levels 2.5x. Reasons for change: Maintained steady levels.
GXO IQ: The company has begun scaling the GXO IQ platform, an AI-powered warehouse technology platform, targeting deployment at more than 50 sites by year-end. This platform improves start-up efficiency, accelerates productivity, and enhances data security.
Automation and Robotics: Deployment of automated solutions, including autonomous mobile robots in the Netherlands and the first auto-load solution in Europe, is advancing. Humanoid pilots are planned for the U.S. and Europe later this year.
New Business Wins: Secured $227 million in new contracts in Q1 2026, including aerospace and defense, AI cloud infrastructure, NHS expansion in the U.K., and a partnership with L'Oreal in Europe.
Sales Pipeline: The sales pipeline reached $2.7 billion, the highest in GXO's history, with 40% of wins in strategic growth verticals like aerospace, defense, life sciences, and technology.
Operational Framework: Launched 'GXO Way,' a global framework for standardizing and scaling operational excellence, aimed at driving consistent execution and margin expansion.
Financial Performance: Achieved $3.3 billion in revenue (up 11% YoY), $200 million in adjusted EBITDA (up 23% YoY), and adjusted EPS of $0.50 (up 72% YoY).
Strategic Priorities: Focused on sharpening commercial execution, strengthening operational discipline, and leading in AI and next-generation automation.
Vertical Diversification: Targeting growth in strategic verticals such as aerospace, defense, life sciences, and technology, with 40% of Q1 wins in these areas.
Foreign Exchange Rate Fluctuations: The company's results are inherently unpredictable and may be materially affected by fluctuations in foreign exchange rates.
Global Economic Conditions and Consumer Demand: Changes in global economic conditions and consumer demand and spending could materially affect the company's performance.
Labor Market Constraints: Labor market constraints could impact the company's ability to operate efficiently.
Global Supply Chain Constraints: Global supply chain constraints pose a risk to the company's operations and ability to deliver services.
Inflationary Pressures: Inflationary pressures could adversely impact the company's financial performance.
Contract Termination Costs: Certain contract termination costs anticipated in the first quarter are now expected to be incurred over the remainder of the year, which could affect financial outcomes.
Integration of Wincanton: The integration of Wincanton is progressing, but achieving the targeted $60 million run rate cost synergies by year-end 2026 remains a challenge.
Retail and Consumer Volume Softness: Softer volumes in retail and consumer verticals could impact revenue growth.
Complexity of Supply Chains: Increasing complexity in supply chains could pose operational challenges.
Revenue Growth: The company expects organic revenue growth of 4% to 5% for the full year 2026.
Adjusted EBITDA: Guidance for adjusted EBITDA has been raised to a range of $935 million to $975 million for 2026.
Adjusted EPS: Adjusted diluted earnings per share guidance has been raised to a range of $2.90 to $3.20, representing a 22% increase at the midpoint.
Free Cash Flow Conversion: The company maintains guidance for free cash flow conversion at 30% to 40% for 2026.
Incremental Revenue: $870 million in incremental new business revenue has already been secured for 2026, up 19% compared to the same time last year.
Sales Pipeline: The sales pipeline has grown to $2.7 billion, a record for the company, with 40% of wins in strategic growth verticals.
Automation and AI Deployment: The company plans to expand its GXO IQ AI-powered warehouse technology platform to more than 50 sites by the end of 2026.
Operational Framework: The GXO Way, a new global operational framework, is being implemented to standardize and scale operational excellence, driving margin expansion.
The selected topic was not discussed during the call.
The earnings call reflects strong financial guidance, significant new business revenue, and strategic market expansion plans. The Q&A section provides additional insights into a robust sales pipeline, successful operational initiatives, and strategic wins in aerospace and defense. While management avoided some specifics, the overall sentiment is positive, driven by strong growth prospects and successful integration of acquisitions.
GXO's earnings call highlights strong growth prospects, with secured revenues for 2025 and 2026, significant market opportunities, and a robust sales pipeline. The integration of Wincanton and focus on automation are expected to drive margin expansion. Despite lighter Q4 growth, optimistic guidance and strategic investments in high-growth verticals support a positive outlook. The Q&A session reinforced confidence in organic growth and margin improvement. Overall, the sentiment leans positive, suggesting a potential stock price increase in the near term.
The earnings call summary and Q&A highlight strong financial metrics, increased guidance, and promising developments in technology and AI. The NHS contract and Wincanton integration are expected to drive growth, with significant synergies anticipated. Despite some uncertainties in Q4 guidance, the overall sentiment is positive, with strategic focus on high-margin verticals and expansion in healthcare and AI. The raised full-year EBITDA guidance and robust sales pipeline further support a positive outlook for the stock price over the next two weeks.
The earnings call summary and Q&A indicate positive sentiment, with strong new business wins, a growing sales pipeline, and significant cost synergies from the Wincanton acquisition. The company is optimistic about future growth, driven by new business momentum and improved guidance. Additionally, the share buyback strategy and the ERP system implementation are positive factors. While management was cautious about macroeconomic conditions and did not provide detailed financial projections, the overall sentiment and strategic initiatives suggest a positive stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.